ELEDON PHARMACEUTICALS, INC. (ELDN)

Every figure this model derived for ELDN, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2016-12-31.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 9,000 PaymentsToAcquirePropertyPlantAndEquipment 2016-12-31
cash 88,756,000 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 93,091,000 AssetsCurrent 2026-06-30
current liabilities 11,789,000 LiabilitiesCurrent 2026-06-30
equity 33,013,000 StockholdersEquity 2026-06-30
revenue 0 Revenues 2016-12-31
sbc 0 AllocatedShareBasedCompensationExpense 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up ELDN on one particular measure came for.

RatioValue
current ratio7.9
current ratio reported7.9

What to be careful about

What this model itself distrusts about ELDN's figures. Written by the derivation as it ran, not added afterwards.